THURSDAY, Oct. 5, 2023 — For patients with treatment-resistant depression, esketamine nasal spray is superior to extended-release quetiapine with respect to remission at week 8, according to a study published in the Oct. 5 issue of the New England…Original Article
Esketamine Nasal Spray Beneficial for Treatment-Resistant Depression
THURSDAY, Oct. 5, 2023 — For patients with treatment-resistant depression, esketamine nasal spray is superior to extended-release quetiapine with respect to remission at week 8, according to a study published in the Oct. 5 issue of the New England…
